Copyright
©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6180-6193
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6180
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6180
Figure 2 2,4,6-trinitrobenzene sulfonic acid and ethanol colitis model was successfully established.
The macroscopic appearance of the colon in TNBS-treated BALB/c mice. A: The colons were obtained 72 h after intra-rectal TNBS or ethanol treatment and were then photographed; B: TNBS or ethanol (the control group) administration caused variation in bodyweight in the murine model; C: Mean colon length; D, E: The DAI and HAI of mice treated with TNBS or ethanol were assessed. Data are presented as the mean ± SD (n = 4). One of three representative experiments is shown. aP < 0.05 and bP < 0.01 vs the ethanol treatment group. TNBS: 2,4,6-trinitrobenzene sulfonic acid.
-
Citation: Bai JA, Xu GF, Yan LJ, Zeng WW, Ji QQ, Wu JD, Tang QY. SGK1 inhibits cellular apoptosis and promotes proliferation
via the MEK/ERK/p53 pathway in colitis. World J Gastroenterol 2015; 21(20): 6180-6193 - URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6180.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6180